Axogen, Inc. To Host Analyst & Investor Day on March 4th

Core Insights - Axogen, Inc. will hold its Analyst & Investor Day on March 4, 2025, from 9am to 12pm Eastern, featuring key executives discussing business strategies and financial objectives [1][2]. Company Overview - Axogen is a leader in developing and marketing surgical solutions for peripheral nerve injuries, focusing on restoring nerve function and quality of life for patients [4]. - The company offers a comprehensive portfolio of products for both scheduled non-trauma and emergent trauma procedures, addressing various nerve-related conditions [5]. Product Portfolio - Key products include: - Avance Nerve Graft: A processed human nerve allograft for bridging severed nerves [6]. - Axoguard Nerve Connector: An aid for tensionless repair of severed nerves [6]. - Axoguard Nerve Protector: A product to protect and reinforce damaged nerves [6]. - Axoguard HA+ Nerve Protector: A next-generation technology for nerve injury protection [6]. - Avive+ Soft Tissue Matrix: An amniotic membrane allograft for tissue protection during repair [6]. - Axoguard Nerve Cap: A product to protect nerve ends and reduce neuroma development [6]. - The product portfolio is available in multiple countries, including the United States, Canada, Germany, the United Kingdom, Spain, and South Korea [6]. Event Details - A live webcast of the Analyst & Investor Day will be available on Axogen's investor relations website, with a replay accessible for 90 days post-event [3].